Search keyWord :

ANGEL Shines at FHA HoReCa 2024 with Leading Water Purification Solutions

Oct 31, 2024

SINGAPORE,Oct. 31,2024-- FHA HoReCa 2024,Asia\'s leading foodservice and hospitality tradeshow,took place from October 22-25 at the Singapore EXPO. FHA HoReCa focused on the latest trends,technologies

AXOR Makes a Grand Debut at EICMA 2024, Milan: A Global Stage for Innovation and Rider Safety

Oct 31, 2024

BELGAUM,India,Oct. 31,2024-- AXOR,a leading international helmet brand and a subsidiary of the renowned VEGA Auto,is gearing up for its much-anticipated debut at EICMA 2024,the world\'s largest motor

Hyundai Motor Reveals Bold and Efficient Hydrogen FCEV Concept Previewing New Design Language

Oct 31, 2024

Hyundai unveils itsINITIUM hydrogen fuel cell electric concept vehicle,reinforcing its clear commitment to hydrogen mobility and sustainability

Agoda Highlights 7 Ski Destinations for Winter Sport Enthusiasts

Oct 31, 2024

SINGAPORE,Oct. 31,2024-- As the year draws to a close and winter sets in on the Northern hemisphere,many travelers look to the slopes for their seasonal adventures. Digital travel platform Agoda shar

Regal Hotels Pioneers Green Meetings Elevating Sustainable Practices for MICE Events in Hong Kong

Oct 31, 2024

HONG KONG,Oct. 30,2024-- Regal Hotels is proud to introduce Green Meetings,a unique,all-in-one business solution designed to empower event organisers to achieve their sustainable goals. By collaborat

A bond forged through the fragrance

Oct 31, 2024

GONGQINGCHENG,China,Oct. 31,2024--A report from Jiangxi International Communication Center(JXICC): In Gongqingcheng,there is an intangible heritage called Tan Hua Fragrance,a kind of Chinese tradition

BRICS Summit safeguards the stability of greater BRICS collaboration

Oct 31, 2024

BEIJING,Oct. 31,2024-- A news report byChina.org.cn on the 16th BRICS Summit:  

Akeso Announces First Patient Enrollment in Phase 3 Trial of Ivonescimab Combined with Ligufalimab (CD47) for First-Line Treatment of Head and Neck Squamous Cell Carcinoma (HNSCC), Compared to Pembrolizumab

Oct 31, 2024

HONG KONG,Oct. 31,2024--Akeso Biopharma (9926.HK) is pleased to announce the enrollment of the first patient in its randomized,controlled,multicenter Phase III clinical study (AK117-302) for head and

CNOOC Limited Announces Mero3 Project Commences Production

Oct 31, 2024

HONG KONG,Oct. 31,2024-- CNOOC Limited (the "Company",SEHK: 00883 (HKD Counter) and 80883 (RMB Counter),SSE: 600938) announces that Mero3 Project has commenced production safely.

MOIN Successfully Complete POC for Cross-Border Tuition Payments, Paving the Way for Solution Commercialization

Oct 31, 2024

SEOUL,South Korea,Oct. 31,2024-- MOIN,a leading cross-border remittance service provider,has successfully collaborated with Visa to address a long-standing challenge in cross-border payments: the inab

1 ... 850 851 852 853 854 855 856 ... 1260